# Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects

> **NCT04838639** · PHASE1 · COMPLETED · sponsor: **Otsuka Pharmaceutical Factory, Inc.** · enrollment: 84 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** NO-13065
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04838639
- **Lead sponsor:** Otsuka Pharmaceutical Factory, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-14
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04838639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04838639, "Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04838639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*